Prospective study comparing mitomycin C or bevacizumab as adjuvant in trabeculectomy revision by needling.

Purpose: To compare the use of mitomycin C (MMC) or bevacizumab (BEV) as adjunctive in the needling revision of failed trabeculectomy blebs.

Methods: Glaucoma patients with failed trabeculectomy were included. Cystic blebs were excluded.

[Neurological manifestations of Behcet's disease: 22 cases among 170 patients].

Objectives: To present neurological involvement in Behçet's disease, its prognosis and treatment.

Methods: Our study was retrospective and was done at Hotel-Dieu Hospital of Beirut between 1980 and 2005. All these patients fulfilled the International Study Group criteria for diagnosis of Behçet's disease.

[Human brucellosis in Lebanon. Clinical features and therapeutic responses in 88 patients].

Objectives: Present clinical features of brucellosis in Lebanon.

Methods: Eighty-eight patients were seen at Hotel-Dieu de France Hospital of Beirut between 1994 and 2002. Diagnostic criteria were brucellar agglutinins at a titer; 1/160 with symptoms suggestive of brucellosis in the absence of other diagnosis and a therapeutic response.

Vascular manifestations of Behçet's disease. Eighteen cases among 140 patients.

Objectives: To describe the features, prognosis, and treatment of vascular involvement in Behçet's disease (BD).

Patients: Among 140 patients with BD seen at the Hôtel-Dieu Hospital in Beirut between 1980 and 2000, 18 (13%) had vascular involvement and were included in this retrospective study. All these patients fulfilled International Study Group criteria for BD.